Valuation: Tempus AI, Inc.

Market Cap 12.69B 11.34B 10.58B 9.61B 18.1B 1,228B 18.24B 127B 49.68B 624B 47.65B 46.62B 2,008B P/E 2026 *
-50.5x
P/E 2027 * -53.9x
Enterprise Value 13.29B 11.88B 11.08B 10.06B 18.95B 1,286B 19.1B 133B 52.02B 654B 49.9B 48.82B 2,102B EV / Sales 2026 *
8.33x
EV / Sales 2027 * 6.71x
Free-Float
61.4%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 01/08/2015
Director of Finance/CFO 40 01/08/2017
Chief Administrative Officer 55 01/06/2020
Director TitleAgeSince
Chairman 56 01/08/2015
Director/Board Member 53 29/10/2019
Director/Board Member 74 01/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-4.62%-12.00% - - 12.69B
-3.19%-3.19%+44.60%+87.98% 74.68B
-15.86%-16.16%+2.68%+51.09% 58.7B
-2.23%+0.68%+3.60%+31.56% 48.36B
-9.79%-11.12%+282.69%+618.49% 43.05B
-2.10%-2.66%+26.52%+27.19% 42.48B
-5.94%-4.50%-2.41%+98.29% 41.39B
-2.13%+1.07%+7.51%+50.31% 31.29B
-2.76%-4.45%-12.93%-15.34% 23.93B
-4.41%-10.02%-39.62%+298.63% 22.22B
Average -5.31%-2.63%+34.74%+138.69% 42.9B
Weighted average by Cap. -5.82%-1.88%+41.19%+131.54%

Financials

2026 *2027 *
Net sales 1.6B 1.43B 1.33B 1.21B 2.27B 154B 2.29B 15.98B 6.24B 78.48B 5.99B 5.86B 252B 1.97B 1.76B 1.64B 1.49B 2.8B 190B 2.83B 19.7B 7.7B 96.75B 7.38B 7.22B 311B
Net income -246M -220M -205M -186M -351M -23.79B -353M -2.46B -962M -12.1B -923M -903M -38.89B -236M -211M -197M -179M -337M -22.86B -340M -2.37B -925M -11.63B -887M -868M -37.37B
Net Debt 598M 534M 499M 453M 853M 57.86B 859M 5.99B 2.34B 29.43B 2.25B 2.2B 94.6B 496M 443M 414M 376M 708M 48.01B 713M 4.97B 1.94B 24.42B 1.86B 1.82B 78.49B
Projected Income Statement - Annual - Tempus AI, Inc.
Logo Tempus AI, Inc.
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Employees
3,800
Date Price Change
09/10/26 EUR 60.35 -4.62%
07/10/26 EUR 63.27 -1.91%
06/10/26 EUR 64.50 -13.79%
05/10/26 EUR 74.82 +10.58%
02/10/26 EUR 67.66 -1.50%
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Tempus AI, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
70.35USD
Average target price
70.61USD
Spread / Average Target
+0.37%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Tempus AI, Inc.